Friday, December 11, 2020 10:16:17 AM
Thoughts...
Recent ABCL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 04:09:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:18:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:11:11 PM
- AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635 • Business Wire • 05/11/2026 08:05:00 PM
- AbCellera to Present at Upcoming Investor Conferences in May and June 2026 • Business Wire • 05/07/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 07:08:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 06:10:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 06:07:23 PM
- AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call • Business Wire • 04/20/2026 01:00:00 PM
- AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 • Business Wire • 04/01/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 07:16:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/24/2026 09:46:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 09:38:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 09:15:09 PM
- AbCellera Reports Full Year 2025 Business Results • Business Wire • 02/24/2026 09:05:00 PM
- AbCellera to Present at Upcoming Investor Conferences in March and April 2026 • Business Wire • 02/11/2026 09:05:00 PM
- AbCellera to Report Full Year 2025 Financial Results on February 24, 2026 • Business Wire • 01/22/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2026 10:09:38 PM
- AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause • Business Wire • 01/12/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 05:11:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 05:10:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 05:08:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 06:24:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 07:43:39 PM
- AbCellera and Bruker Reach Global Settlement of Patent Litigation • Business Wire • 12/18/2025 02:00:00 PM
